Vivo Biosciences Overview
- Year Founded
-
2004
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Investors
-
2
Vivo Biosciences General Information
Description
Provider of preclinical drug discovery services. The company has developed new all-human bioassay platforms for preclinical research, drug discovery and therapeutics. Its patented HuBiogel technology emulates the biology of normal and disease tissues in vitro.
Contact Information
Website
www.vivobiotech.comCorporate Office
- 1601 12th Avenue South
- Birmingham, AL 35205
- United States
Corporate Office
- 1601 12th Avenue South
- Birmingham, AL 35205
- United States
Vivo Biosciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Merger/Acquisition | 02-Nov-2016 | Completed | Generating Revenue | |||
| 4. Grant | 22-Sep-2015 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series B) | 29-Oct-2010 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A) | 01-Dec-2007 | $2M | $2M | Completed | Startup | |
| 1. Grant | 01-Sep-2006 | $750K | Completed | Generating Revenue |
Vivo Biosciences Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A |
Vivo Biosciences Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Vivo Biosciences Former Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Greer Capital Advisors | Venture Capital | Minority | ||
| Toucan Capital | Venture Capital | Minority |
Vivo Biosciences Acquisitions (1)
Vivo Biosciences’s most recent deal was a Merger/Acquisition with Sacred Cells Research Partner. The deal was made on 22-Dec-2014.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Sacred Cells Research Partner | 22-Dec-2014 | Merger/Acquisition | Biotechnology |
Vivo Biosciences FAQs
-
When was Vivo Biosciences founded?
Vivo Biosciences was founded in 2004.
-
Where is Vivo Biosciences headquartered?
Vivo Biosciences is headquartered in Birmingham, AL.
-
What industry is Vivo Biosciences in?
Vivo Biosciences’s primary industry is Drug Discovery.
-
Is Vivo Biosciences a private or public company?
Vivo Biosciences is a Private company.
-
What is Vivo Biosciences’s current revenue?
The current revenue for Vivo Biosciences is .
-
How much funding has Vivo Biosciences raised over time?
Vivo Biosciences has raised $5M.
-
Who are Vivo Biosciences’s investors?
Greer Capital Advisors and Toucan Capital have invested in Vivo Biosciences.
-
When was Vivo Biosciences acquired?
Vivo Biosciences was acquired on 02-Nov-2016.
-
Who acquired Vivo Biosciences?
Vivo Biosciences was acquired by LifeNet Health.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
